INVO Fertility, Inc. Research and Development Expense
INVO Fertility, Inc. (IVF) reported Research and Development Expense of $265.66 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-06-02
- INVO Fertility, Inc. research and development expense for the quarter ending 2025-03-31 was $265.66K, a 5343.91% increase year-over-year.
- INVO Fertility, Inc. research and development expense for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- INVO Fertility, Inc. research and development expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- INVO Fertility, Inc. research and development expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- INVO Fertility, Inc. research and development expense for fiscal 2024 was $4.88K, a 97.06% decline from fiscal 2023.
- INVO Fertility, Inc. research and development expense for fiscal 2023 was $165.94K, a 69.50% decline from fiscal 2022.
- INVO Fertility, Inc. research and development expense for fiscal 2022 was $544.04K, a 151.37% increase from fiscal 2021.
- INVO Fertility, Inc. research and development expense for fiscal 2021 was $216.43K, a 45.68% decline from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 54 month | Research and Development Expense 57 month |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | $265.66K 10-Q · filed 2025-05-20 | $265.66K derived: sum of 2 quarters · filed 2026-06-02 | $265.66K derived: sum of 3 quarters · filed 2026-06-02 | $265.66K derived: sum of 4 quarters · filed 2026-06-02 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $0.00 derived: sum of 2 quarters · filed 2026-06-02 | $0.00 derived: sum of 3 quarters · filed 2026-06-02 | $4.88K 10-K · filed 2026-06-02 | $489.66K 10-K · filed 2025-04-30 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $0.00 derived: sum of 2 quarters · filed 2025-11-17 | $4.88K 10-Q · filed 2025-11-17 | $10.79K derived: sum of 4 quarters · filed 2025-11-17 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $4.88K 10-Q · filed 2025-08-14 | $10.79K derived: sum of 3 quarters · filed 2025-08-14 | $13.46K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $4.88K 10-Q · filed 2025-05-20 | $10.79K derived: sum of 2 quarters · filed 2025-05-20 | $13.46K derived: sum of 3 quarters · filed 2025-05-20 | $97.31K derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | $5.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $8.57K derived: sum of 2 quarters · filed 2025-04-30 | $92.42K derived: sum of 3 quarters · filed 2025-04-30 | $165.94K 10-K · filed 2025-04-30 | |||
| 2023-09-30 | $2.67K 10-Q · filed 2024-11-19 | $86.52K derived: sum of 2 quarters · filed 2024-11-19 | $160.04K 10-Q · filed 2024-11-19 | $233.87K derived: sum of 4 quarters · filed 2024-11-19 | |||
| 2023-06-30 | $83.85K 10-Q/A · filed 2024-11-19 | $157.37K 10-Q/A · filed 2024-11-19 | $231.21K derived: sum of 3 quarters · filed 2024-11-19 | $406.47K derived: sum of 4 quarters · filed 2024-11-19 | |||
| 2023-03-31 | $73.52K 10-Q · filed 2024-05-15 | $147.35K derived: sum of 2 quarters · filed 2024-11-19 | $322.62K derived: sum of 3 quarters · filed 2024-11-19 | $513.38K derived: sum of 4 quarters · filed 2024-11-19 | |||
| 2022-12-31 | $73.83K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | $249.10K derived: sum of 2 quarters · filed 2024-11-19 | $439.86K derived: sum of 3 quarters · filed 2024-11-19 | $544.04K 10-K/A · filed 2024-11-19 | |||
| 2022-09-30 | $175.27K 10-Q · filed 2023-11-13 | $366.03K derived: sum of 2 quarters · filed 2023-11-13 | $470.21K 10-Q · filed 2023-11-13 | $533.96K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $190.76K 10-Q · filed 2023-08-14 | $294.94K 10-Q · filed 2023-08-14 | $358.70K derived: sum of 3 quarters · filed 2023-08-14 | $414.09K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $104.18K 10-Q · filed 2023-05-15 | $167.94K derived: sum of 2 quarters · filed 2023-05-15 | $223.33K derived: sum of 3 quarters · filed 2023-05-15 | $254.34K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $63.76K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $119.15K derived: sum of 2 quarters · filed 2023-04-17 | $150.16K derived: sum of 3 quarters · filed 2023-04-17 | $216.43K 10-K · filed 2023-04-17 | |||
| 2021-09-30 | $55.39K 10-Q · filed 2022-11-14 | $86.41K derived: sum of 2 quarters · filed 2022-11-14 | $152.67K 10-Q · filed 2022-11-14 | $373.61K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $31.02K 10-Q · filed 2022-08-15 | $97.28K 10-Q · filed 2022-08-15 | $318.22K derived: sum of 3 quarters · filed 2022-08-15 | $430.77K derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $66.27K 10-Q · filed 2022-05-16 | $287.20K derived: sum of 2 quarters · filed 2022-05-16 | $399.75K derived: sum of 3 quarters · filed 2022-05-16 | $434.64K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $220.93K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $333.49K derived: sum of 2 quarters · filed 2022-03-31 | $368.38K derived: sum of 3 quarters · filed 2022-03-31 | $398.43K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $112.55K 10-Q · filed 2021-11-15 | $147.44K derived: sum of 2 quarters · filed 2021-11-15 | $177.49K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $34.89K 10-Q · filed 2021-08-16 | $64.94K 10-Q · filed 2021-08-16 | |||||
| 2020-03-31 | $30.05K 10-Q · filed 2021-05-17 | ||||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 | ||||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 derived: sum of 3 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 derived: sum of 2 quarters · filed 2020-08-13 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | ||||||
| 2011-09-30 | $0.00 derived: 10-Q 57 month − 10-Q 54 month · filed 2011-11-21 | $92.76K 10-Q · filed 2011-11-21 | |||||
| 2011-06-30 | $92.76K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |